超速赖脯胰岛素在运动前基础率调整中相比赖脯胰岛素改善药代动力学并减少运动相关低血糖
结果显示URLi在50%和100% BRR策略下均显著减轻运动期间血糖下降,且运动期间低血糖发生率数值上更低(6% vs 16%)。
要点
- URLi在运动前BRR时比赖脯胰岛素更有效减轻血糖下降。
- URLi运动期间低血糖发生率数值上低于赖脯胰岛素(6% vs 16%)。
- URLi运动后餐后降糖更早,因吸收更快。
核心结论
- 在常规CSII中,URLi相比赖脯胰岛素能更有效地实现运动前基础率降低,并减少活动性成人1型糖尿病患者的低血糖事件。
主要发现
- 50% BRR时运动期间血糖变化URLi为-26.8±37 mg/dL,赖脯胰岛素为-39.0±39 mg/dL(P<0.05)。
- 100% BRR时运动期间血糖变化URLi为-46.9±32 mg/dL,赖脯胰岛素为-60.5±39 mg/dL(P<0.01)。
- 运动前15分钟循环胰岛素浓度上升,但每种BRR策略下URLi的最大浓度低于赖脯胰岛素。
- 运动期间低血糖发生率URLi为6%,赖脯胰岛素为16%(数值上更低)。
- 运动后餐后URLi吸收更快,降糖更早。
临床怎么用
- 对于使用常规CSII的活动性1型糖尿病成人,运动前手动降低基础率时选用URLi可能比赖脯胰岛素更有效减少运动相关低血糖。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the glycemic response and pharmacokinetics (PK) of ultra-rapid lispro (URLi) versus lispro during manual basal rate reductions (BRRs) before exercise with conventional continuous subcutaneous insulin infusion (CSII) in active adults with type 1 diabetes. RESEARCH DESIGN AND METHODS: This study was a double-blind, four-period, crossover, randomized controlled trial. Exercise (60 min walking at 45-55% VO2max) was performed 4 h after a standardized meal, with either a 50% (-60 min) or 100% (-15 min) BRR before exercise using URLi or lispro. The primary end point was the change in glucose during exercise, and insulin lispro PK was the secondary end point. RESULTS: Twenty-five participants (mean ± SD age 36.7 ± 10.3 years; mean ± SD HbA1c 50.4 ± 8.5 mmol/mol [6.76 ± 0.8%]; 48% female) completed the study. URLi significantly attenuated the reduction in glucose level compared with lispro during both the 50% BRR (-26.8 ± 37 vs. -39.0 ± 39 mg/dL; P < 0.05) and the 100% BRR (-46.9 ± 32 vs. -60.5 ± 39 mg/dL; P < 0.01). Circulating insulin lispro concentrations rose in the first 15 min of exercise, but maximum concentration was lower with URLi versus lispro within each BRR strategy. Numerically less hypoglycemia was observed during exercise with URLi (6%) compared with lispro (16%). Following a postexercise meal, faster insulin absorption of URLi resulted in an earlier postprandial glucose lowering compared with lispro. CONCLUSIONS: Using URLi in conventional CSII pump therapy provides more effective BRRs prior to exercise compared with lispro, with fewer hypoglycemic events in active adults with type 1 diabetes.
引用
- Leohr JK, Abitbol A, Turner LV, et al. Ultra-Rapid Lispro Has an Improved Pharmacokinetic Profile for Exercise Compared With Lispro, Resulting in Less Exercise-Associated Hypoglycemia in Adults With Type 1 Diabetes on Open-Loop Continuous Subcutaneous Insulin Infusion. Diabetes Care. 2026. PMID: 41885780. doi:10.2337/dc25-2294
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。